Anatomic Pathology Market 2022-2028

Description

List of Tables

Global Anatomic Pathology Market Size, Share & Trends Analysis Report by Products and Services (Anesthesiology, Consumables, Services, and Instruments), by Application (Disease Diagnosis and Drug Discovery), and by End-Users (Hospitals, Clinical Laboratory, Physician Laboratory, and Others) Forecast Period (2022-2028)

The global anatomic pathology market is anticipated to grow at a substantial CAGR of around 6.2% during the forecast period. The factor that drives the global anatomic pathology market is the rising number of chronic diseases, which in turn, is increasing biopsies. Any failure to deal with a large number of biopsies or comply with recommendations for cancer cases or other sample handling or additional testing may pose a major challenge to market growth. Improvement in turnaround time is another critical element of management, which act as a barrier to the growth of the global anatomic pathology market.

The global anatomic pathology market is segmented based on products and services, applications, and end-users. Based on the products and services, the market is sectioned as anesthesiology, consumables, services, and instruments. Based on the applications, the market is sectioned as disease diagnosis and drug discovery. Based on the end-users, the market is sectioned as hospitals, clinical laboratories, physician laboratories, and others. The above-mentioned segments can be customized as per the requirements. Among these, the service segment is expected to cater to a significant share in the global anatomic pathology market due to the availability of rebates for diagnostic tests, immediate growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases. . According to the American Cancer Society, Inc. in 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer mortalities in the US.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America has accounted for the largest revenue share due to the existence of major players and supportive government initiatives on training pathological programs. There is also easy accessibility to developed technologies, government initiatives for screening cancer patients, favorable reimbursement scenarios for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the Anatomic Pathology market in North America.

The major companies serving the global anatomic pathology market Abcam plc., Abbott Laboratories, Agilent Technologies, Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, F. Hoffmann-La Roche Ltd introduced three new automated digital pathology algorithms, uPath Ki-67 (30-9), uPath ER (SP1), and uPath PR (1E2) image analysis for breast cancer, which are important biomarkers for breast cancer patients. These new algorithms achieve the Roche digital pathology breast panel of image analysis algorithms.

Research Methodology

The market study of the global anatomic pathology market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Anatomic pathology Market Research And Analysis By Product and Services

2. Global Anatomic pathology Market Research And Analysis By Application

3. Global Anatomic pathology Market Research And Analysis By End-User

The Report Covers:

Comprehensive Research Methodology of the global anatomic pathology market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global anatomic pathology market.
Insights about market determinants that are stimulating the global anatomic pathology market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026487

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Anatomic Pathology Market
Recovery Scenario of Global Anatomic Pathology Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Agilent Technologies, Inc.
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Danaher Corp.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Abcam plc
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Abbott Laboratories
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. F. Hoffmann-La Roche Ltd
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Anatomic Pathology Market by Products and Services
- 4.1.1. Anesthesiology
- 4.1.2. Consumables
- 4.1.3. Services
- 4.1.4. Instruments
4.2. Global Anatomic Pathology Market by Application
- 4.2.1. Disease Diagnosis
- 4.2.2. Drug Discovery
4.3. Global Anatomic Pathology Market by End Users
- 4.3.1. Hospitals
- 4.3.2. Clinical Laboratory
- 4.3.3. Physician Laboratory
- 4.3.4. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Advanced Cell Diagnostics, Inc.
6.2. Bio SB
6.3. Biocare Medical, LLC.
6.4. Biocartis NV
6.5. BioGenex Laboratories, Inc
6.6. Bruker Corp.
6.7. Diapath S.p.A.
6.8. Histo-line Laboratories
6.9. Laboratory Corporation of America
6.10. Lupetec
6.11. NeoGenomics Laboratories, Inc.
6.12. PHC Holdings Corp.
6.13. Quest Diagnostics Inc
6.14. Sakura Finetek USA, Inc.
6.15. Tecan Trading AG